Anti-JCV Antibody Prevalence in a French Cohort of MS Patients under Natalizumab

被引：0
|
作者：
Outteryck, Olivier [1 ]
Ongagna, Jean-Claude [2 ]
Zephir, Helene [1 ]
Collongues, Nicolas [2 ]
Lacour, Arnaud [1 ]
Fleury, Marie [2 ]
Berteloot, Anne-Sophie [1 ]
Blanc, Frederic [2 ]
Giroux, Marianne [1 ]
Vermersch, Patrick [1 ]
De Seze, Jerome [2 ]
机构：
[1] Univ Lille Nord France, Lille, France
[2] Univ Strasbourg, Strasbourg, France
来源：
NEUROLOGY | 2012年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P02141
引用
收藏
页数：3
相关论文
共 50 条
  • [21] No changes in anti-JCV antibody status after Natalizumab discontinuation in a large population of Multiple Sclerosis patients
    Sgarlata, E.
    Chisari, C. G.
    D'Amico, E.
    Toscano, S.
    Zanghi, A.
    Lo Fermo, S.
    Patti, F.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 325 - 325
  • [22] Anti-JCV Antibody Prevalence in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Natalizumab: Baseline Results of STRATIFY-2
    Bozic, Carmen
    Richman, Sandra
    Plavina, Tatiana
    Natarajan, Amy
    Scanlon, James
    Subramanyam, Meena
    Sandrock, Alfred
    Bloomgren, Gary
    NEUROLOGY, 2012, 78
  • [23] ANTI-JCV TITRES INCREASE OVER TIME WITH NATALIZUMAB TREATMENT
    Raffel, Joel
    Gafson, Arie
    Nicholas, Richard
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (11):
  • [24] Natalizumab Risk Stratification: Role of a Two- Step Anti-JCV Antibody Assay
    O'Connor, Paul W.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2012, 39 (05) : 670 - 675
  • [25] Prevalence of anti-JCV antibodies in a multi-national cohort of multiple sclerosis patients
    Olsson, T.
    Achiron, A.
    Alfredsson, L.
    Chan, A.
    Comi, G.
    Hillert, J.
    Moiola, L.
    Oturai, A.
    Sorensen, P.
    Potts, J.
    Hotermans, C.
    Plavina, T.
    Paes, D.
    Subramanyam, M.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S134 - S135
  • [26] Anti-JCV Antibodies Detection and JCV DNA Levels in PBMC, Serum and Urine in a Cohort of Spanish Multiple Sclerosis Patients Treated with Natalizumab
    Inmaculada Dominguez-Mozo, Maria
    Garcia-Montojo, Marta
    De Las Heras, Virginia
    Garcia-Martinez, Angel
    Maria Arias-Leal, Ana
    Casanova, Ignacio
    Arroyo, Rafael
    Alvarez-Lafuente, Roberto
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2013, 8 (05) : 1277 - 1286
  • [27] Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort
    Dominguez-Mozo, Maria I.
    Rus, Macarena
    Santiago, Jose L.
    Izquierdo, Guillermo
    Casanova, Ignacio
    Galan, Victoria
    Angel Garcia-Martinez, M.
    Arias-Leal, Ana M.
    Garcia-Montojo, Marta
    Perez-Perez, Silvia
    Arroyo, Rafael
    Alvarez-Lafuente, Roberto
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 (02) : 158 - 166
  • [28] Anti-JCV antibody serology is associated with CSF cell counts in multiple sclerosis patients with and without natalizumab treatment
    Schneider-Hohendorf, T.
    Schulte-Mecklenbeck, A.
    Ostkamp, P.
    Luessi, F.
    Klotz, L.
    Zipp, F.
    Wiendl, H.
    Gross, C. C.
    Schwab, N.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 1007 - 1007
  • [29] Anti-JCV Antibodies Detection and JCV DNA Levels in PBMC, Serum and Urine in a Cohort of Spanish Multiple Sclerosis Patients Treated with Natalizumab
    Maria Inmaculada Dominguez-Mozo
    Marta Garcia-Montojo
    Virginia De Las Heras
    Angel Garcia-Martinez
    Ana María Arias-Leal
    Ignacio Casanova
    Rafael Arroyo
    Roberto Alvarez-Lafuente
    Journal of Neuroimmune Pharmacology, 2013, 8 : 1277 - 1286
  • [30] Anti-JCV Antibodies Are Consistently Detected Prior to and after PML Diagnosis in Natalizumab-Treated MS Patients
    Subramanyam, Meena
    Plavina, Tatiana
    Lee, Sophia
    Njenga, Moses
    Berman, Melissa
    Gorelik, Leonid
    Natarajan, Amy
    Schlain, Brian
    Richman, Sandra
    Goelz, Susan
    Bozic, Carmen
    Sandrock, Alfred
    NEUROLOGY, 2011, 76 (09) : A636 - A637
12345